4//SEC Filing
Power Sean A 4
Accession 0001104659-22-002361
CIK 0001001316other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 6:11 PM ET
Size
7.0 KB
Accession
0001104659-22-002361
Insider Transaction Report
Form 4
Power Sean A
CFO
Transactions
- Sale
COMMON STOCK
2022-01-05$18.31/sh−9,653$176,746→ 568,483 total - Sale
COMMON STOCK
2022-01-04$19.20/sh−75,312$1,445,990→ 578,136 total
Footnotes (2)
- [F1]In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Includes shares of restricted Common Stock, which are subject to vesting and 140,000 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing.
Documents
Issuer
TG THERAPEUTICS, INC.
CIK 0001001316
Entity typeother
Related Parties
1- filerCIK 0001538845
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 6:11 PM ET
- Size
- 7.0 KB